Immunohistological Insight into the Correlation between Neuropilin-1 and Epithelial-Mesenchymal Transition Markers in Epithelial Ovarian Cancer

Journal of Histochemistry and Cytochemistry

Volumn 62, Issue 9, 2014, Pages 619-631

  Adham, Sirin A I ^a   Al Harrasi, Ibtisam ^a   Al Haddabi, Ibrahim ^b   Al Rashdi, Afrah ^b   Al Sinawi, Shadia ^b   Al Maniri, Abdullah ^c,d   Ba Omar, Taher ^a   Coomber, Brenda L ^e  

^a College of Science   (Oman)

^b Department of Food Science and Nutrition   (Oman)

^c SULTAN QABOOS UNIVERSITY   (Oman)

^d THE RESEARCH COUNCIL   (Oman)

^e UNIVERSITY OF GUELPH   (Canada)

Author keywords

biomarker; E cadherin; EMT; neuropilin 1; OSE; slug; vimentin

Indexed keywords

NERVE CELL ADHESION MOLECULE; NEUROPILIN 1; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VIMENTIN; BIOLOGICAL MARKER; CADHERIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; CELLULAR DISTRIBUTION; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; TISSUE DISTRIBUTION; TISSUE MICROARRAY; CYTOLOGY; E-CADHERIN; EMT; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; OSE; OVARY; OVARY TUMOR; PATHOLOGY; PROTEIN TRANSPORT; SLUG;

BIOMARKER; E-CADHERIN; EMT; NEUROPILIN-1; OSE; SLUG; VIMENTIN;

CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEUROPILIN-1; OVARIAN NEOPLASMS; OVARY; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907891290     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155414538821     Document Type: Article

References (70)

1. Adham SA,Sher I,Coomber BL.Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.Lab Invest. 2010;90:709-723
2. Ahmed N,Thompson EW,Quinn MA.Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.J Cell Physiol. 2007;213:581-588
3. Arlt MJ,Novak-Hofer I,Gast D,Gschwend V,Moldenhauer G,Grunberg J,Honer M,Schubiger PA,Altevogt P,Kruger A.Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.Cancer Res. 2006;66:936-943
4. Auersperg N,Wong AS,Choi KC,Kang SK,Leung PC.Ovarian surface epithelium: biology, endocrinology, and pathology.Endocr Rev. 2001;22:255-288
5. Baba T,Kariya M,Higuchi T,Mandai M,Matsumura N,Kondoh E,Miyanishi M,Fukuhara K,Takakura K,Fujii S.Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition.Gynecol Oncol. 2007;105:703-711
6. Bamias A,Psaltopoulou T,Sotiropoulou M,Haidopoulos D,Lianos E,Bournakis E,Papadimitriou C,Rodolakis A,Vlahos G,Dimopoulos MA.Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.Cancer. 2010;116:1462-1468
7. Blazquez C,Cook N,Micklem K,Harris AL,Gatter KC,Pezzella F.Phosphorylated KDR can be located in the nucleus of neoplastic cells.Cell Res. 2006;16:93-98
8. Bracke ME.Role of adhesion molecules in locoregional cancer spread.Cancer Treat Res. 2007;134:35-49
9. Cannistra SA.Cancer of the ovary.N Engl J Med. 2004;351:2519-2529
10. Chauhan SC,Kumar D,Jaggi M.Mucins in ovarian cancer diagnosis and therapy.J Ovarian Res. 2009;2:21
11. Chauhan SC,Singh AP,Ruiz F,Johansson SL,Jain M,Smith LM,Moniaux N,Batra SK.Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16.Mod Pathol. 2006;19:1386-1394
12. Chen K,Gentry-Maharaj A,Burnell M,Steentoft C,Marcos-Silva L,Mandel U,Jacobs I,Dawnay A,Menon U,Blixt O.Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer.J Proteome Res. 2013;12:1408-1418
13. Cheng JC,Auersperg N,Leung PC.EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?.PLoS One. 2012;7:e34071
14. Choi J,Park SY,Joo CK.Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells.Invest Ophthalmol Vis Sci. 2007;48:2708-2718
15. Chui X,Egami H,Yamashita J,Kurizaki T,Ohmachi H,Yamamoto S,Ogawa M.Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues.Br J Cancer. 1996;73:1233-1236
16. D’Andrilli G,Giordano A,Bovicelli A.Epithelial ovarian cancer: the role of cell cycle genes in the different histotypes.Open Clin Cancer J. 2008;2:7-12
17. Davidson B,Trope CG,Reich R.Epithelial-mesenchymal transition in ovarian carcinoma.Front Oncol. 2012;2:33
18. Domingues I,Rino J,Demmers JA,de Lanerolle P,Santos SC.VEGFR2 translocates to the nucleus to regulate its own transcription.PLoS One. 2011;6:e25668
19. Ellis LM.The role of neuropilins in cancer.Mol Cancer Ther. 2006;5:1099-1107
20. Fox SB,Turley H,Cheale M,Blazquez C,Roberts H,James N,Cook N,Harris A,Gatter K.Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus.J Pathol. 2004;202:313-320
21. Glinka Y,Stoilova S,Mohammed N,Prud’homme GJ.Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta.Carcinogenesis. 2011;32:613-621
22. Hall GH,Turnbull LW,Bedford K,Richmond I,Helboe L,Atkin SL.Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours.Int J Oncol. 2005;27:1283-1288
23. Hennessy BT,Coleman RL,Markman M.Ovarian cancer.Lancet. 2009;374:1371-1382
24. Herzog B,Pellet-Many C,Britton G,Hartzoulakis B,Zachary IC.VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.Mol Biol Cell. 2011;22:2766-2776
25. Hong TM,Chen YL,Wu YY,Yuan A,Chao YC,Chung YC,Wu MH,Yang SC,Pan SH,Shih JY,Chan WK,Yang PC.Targeting neuropilin 1 as an antitumor strategy in lung cancer.Clin Cancer Res. 2007;13:4759-4768
26. Hu B,Guo P,Bar-Joseph I,Imanishi Y,Jarzynka MJ,Bogler O,Mikkelsen T,Hirose T,Nishikawa R,Cheng SY.Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.Oncogene. 2007;26:5577-5586
27. Hu CT,Chang TY,Cheng CC,Liu CS,Wu JR,Li MC,Wu WS.Snail associates with EGR-1 and SP-1 to upregulate transcriptional activation of p15INK4b.FEBS J. 2010;277:1202-1218
28. Hudson LG,Zeineldin R,Stack MS.Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.Clin Exp Metastasis. 2008;25:643-655
29. Ichigo S,Takagi H,Matsunami K,Murase T,Ikeda T,Imai A.Transitional cell carcinoma of the ovary (Review).Oncol Lett. 2012;3:3-6
30. Jacobs IJ,Rivera H,Oram DH,Bast RC.Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3.Br J Obstet Gynaecol. 1993;100:1120-1124
31. Jubb AM,Miller KD,Rugo HS,Harris AL,Chen D,Reimann JD,Cobleigh MA,Schmidt M,Langmuir VK,Hillan KJ,Chen DS,Koeppen H.Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.Clin Cancer Res. 2011;17:372-381
32. Karst AM,Drapkin R.Ovarian cancer pathogenesis: a model in evolution.J Oncol. 2010;2010:932371
33. Kiefel H,Bondong S,Pfeifer M,Schirmer U,Erbe-Hoffmann N,Schafer H,Sebens S,Altevogt P.EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-kappaB activation.Carcinogenesis. 2012;33:1919-1929
34. Kim JY,Kim YM,Yang CH,Cho SK,Lee JW,Cho M.Functional regulation of Slug/Snail2 is dependent on GSK-3beta-mediated phosphorylation.FEBS J. 2012;279:2929-2939
35. Kreuter M,Woelke K,Bieker R,Schliemann C,Steins M,Buechner T,Berdel WE,Mesters RM.Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia.Leukemia. 2006;20:1950-1954
36. Lalwani N,Prasad SR,Vikram R,Shanbhogue AK,Huettner PC,Fasih N.Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.Radiographics. 2011;31:625-646
37. Lambrechts D,Lenz HJ,de Haas S,Carmeliet P,Scherer SJ.Markers of response for the antiangiogenic agent bevacizumab.J Clin Oncol. 2013;31:1219-1230
38. Levanon K,Crum C,Drapkin R.New insights into the pathogenesis of serous ovarian cancer and its clinical impact.J Clin Oncol. 2008;26:5284-5293
39. Lu Y,Xiang H,Liu P,Tong RR,Watts RJ,Koch AW,Sandoval WN,Damico LA,Wong WL,Meng YG.Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration.MAbs. 2009;1:364-369
40. Mak P,Leav I,Pursell B,Bae D,Yang X,Taglienti CA,Gouvin LM,Sharma VM,Mercurio AM.ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.Cancer Cell. 2010;17:319-332
41. Maru D,Venook AP,Ellis LM.Predictive biomarkers for bevacizumab: are we there yet?.Clin Cancer Res. 2013;19:2824-2827
42. Nakajima S,Doi R,Toyoda E,Tsuji S,Wada M,Koizumi M,Tulachan SS,Ito D,Kami K,Mori T,Kawaguchi Y,Fujimoto K,Hosotani R,Imamura M.N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.Clin Cancer Res. 2004;10:4125-4133
43. Nieman MT,Prudoff RS,Johnson KR,Wheelock MJ.N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.J Cell Biol. 1999;147:631-644
44. Osada R,Horiuchi A,Kikuchi N,Ohira S,Ota M,Katsuyama Y,Konishi I.Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.Hum Pathol. 2006;37:1414-1425
45. O’Shannessy DJ,Jackson SM,Twine NC,Hoffman BE,Dezso Z,Agoulnik SI,Somers EB.Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.Int J Mol Sci. 2013;14:13687-13703
46. Pan Q,Chanthery Y,Liang WC,Stawicki S,Mak J,Rathore N,Tong RK,Kowalski J,Yee SF,Pacheco G,Ross S,Cheng Z,Le Couter J,Plowman G,Peale F,Koch AW,Wu Y,Bagri A,Tessier-Lavigne M,Watts RJ.Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.Cancer Cell. 2007;11:53-67
47. Peinado H,Olmeda D,Cano A.Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?.Nat Rev Cancer. 2007;7:415-428
48. Ponnusamy MP,Lakshmanan I,Jain M,Das S,Chakraborty S,Dey P,Batra SK.MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.Oncogene. 2010;29:5741-5754
49. Rodriguez FJ,Lewis-Tuffin LJ,Anastasiadis PZ.E-cadherin’s dark side: possible role in tumor progression.Biochim Biophys Acta. 2012;1826:23-31
50. Satelli A,Li S.Vimentin in cancer and its potential as a molecular target for cancer therapy.Cell Mol Life Sci. 2011;68:3033-3046
51. Siegel R,Ward E,Brawley O,Jemal A.Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin. 2011;61:212-236
52. Smart CE,Morrison BJ,Saunus JM,Vargas AC,Keith P,Reid L,Wockner L,Amiri MA,Sarkar D,Simpson PT,Clarke C,Schmidt CW,Reynolds BA,Lakhani SR,Lopez JA.In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.PLoS One. 2013;8:e64388
53. Song MJ,Lee SH,Choi MR,Son HJ,Lee CW,Yoon JH,Park YG,Hur SY,Ryu KS,Lee JM.Diagnostic value of CA125 as a predictor of recurrence in advanced ovarian cancer.Eur J Gynaecol Oncol. 2013;34:148-151
54. Soslow RA.Histologic subtypes of ovarian carcinoma: an overview.Int J Gynecol Pathol. 2008;27:161-174
55. Stephenson JM,Banerjee S,Saxena NK,Cherian R,Banerjee SK.Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer.Int J Cancer. 2002;101:409-414
56. Stoeck A,Schlich S,Issa Y,Gschwend V,Wenger T,Herr I,Marme A,Bourbie S,Altevogt P,Gutwein P.L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.Cancer Lett. 2006;239:212-226
57. Sugiyama T,Kumagai S,Hatayama S.[Treatments of epithelial ovarian cancer by histologic subtype].Gan To Kagaku Ryoho. 2009;36:187-192
58. Sundfeldt K.Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule.Mol Cell Endocrinol. 2003;202:89-96
59. Sundfeldt K,Piontkewitz Y,Ivarsson K,Nilsson O,Hellberg P,Brannstrom M,Janson PO,Enerback S,Hedin L.E-cadherin expression in human epithelial ovarian cancer and normal ovary.Int J Cancer. 1997;74:275-280
60. Theriault C,Pinard M,Comamala M,Migneault M,Beaudin J,Matte I,Boivin M,Piche A,Rancourt C.MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis.Gynecol Oncol. 2011;121:434-443
61. Uniewicz KA,Cross MJ,Fernig DG.Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis.J Biol Chem. 2011;286:12-23
62. Vergara D,Merlot B,Lucot JP,Collinet P,Vinatier D,Fournier I,Salzet M.Epithelial-mesenchymal transition in ovarian cancer.Cancer Lett. 2010;291:59-66
63. Viale G,Gambacorta M,Dell’Orto P,Coggi G.Coexpression of cytokeratins and vimentin in common epithelial tumours of the ovary: an immunocytochemical study of eighty-three cases.Virchows Arch A Pathol Anat Histopathol. 1988;413:91-101
64. Wey JS,Gray MJ,Fan F,Belcheva A,McCarty MF,Stoeltzing O,Somcio R,Liu W,Evans DB,Klagsbrun M,Gallick GE,Ellis LM.Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells.Br J Cancer. 2005;93:233-241
65. Wong AS,Maines-Bandiera SL,Rosen B,Wheelock MJ,Johnson KR,Leung PC,Roskelley CD,Auersperg N.Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer.Int J Cancer. 1999;81:180-188
66. Xu J,Xia J.NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo.Exp Ther Med. 2013;5:150-154
67. Yoshida J,Horiuchi A,Kikuchi N,Hayashi A,Osada R,Ohira S,Shiozawa T,Konishi I.Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression.Med Mol Morphol. 2009;42:82-91
68. Yu DC,Waby JS,Chirakkal H,Staton CA,Corfe BM.Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.Mol Cancer. 2010;9:276
69. Zhang Y,Pillai G,Gatter K,Blazquez C,Turley H,Pezzella F,Watt SM.Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study.Hum Pathol. 2005;36:797-805
70. Zhong YC,Zhang T,Di W,Li WP.Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition.J Gynecol Oncol. 2013;24:265-272